EP1348712A1 — L-nucleic acid derivatives and processes for the synthesis thereof
Assigned to Mitsui Chemicals Inc · Expires 2003-10-01 · 23y expired
What this patent protects
A novel method has been found to produce 2,2'-anhydro-1-(β-L-arabinofuranosyl)thymine as a novel useful intermediate compound. A novel method has been further found to produce thymidine from 2,2'-anhydro-1-(β-L-arabinofuranosyl)thymine. A novel method has been further found to L-…
USPTO Abstract
A novel method has been found to produce 2,2'-anhydro-1-(β-L-arabinofuranosyl)thymine as a novel useful intermediate compound. A novel method has been further found to produce thymidine from 2,2'-anhydro-1-(β-L-arabinofuranosyl)thymine. A novel method has been further found to L-2'-deoxyribose derivatives as a useful synthetic intermediate through L-2,2'-anhydro-5,6-dihydrocyclouridine derivative. According to these methods, synthesis of various L-nucleic acid derivatives, synthesis of which has been difficult till now.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.